We then investigated whether CHIP restricts HIV infection in the early phase before/at integration by using HIV-1-GFP, i.e., a VSV-G-pseudotyped single-cycle HIV-1 retroviral vector with a GFP reporter under the control of a cytomegalovirus (CMV) promoter. This evidence concerns the gene STUB1 and HIV infectious disease.